Jump to ContentJump to Main Navigation
Prescription for ChangeThe Looming Crisis in Drug Development$
Users without a subscription are not able to see the full content.

Michael Kinch

Print publication date: 2016

Print ISBN-13: 9781469630625

Published to North Carolina Scholarship Online: May 2017

DOI: 10.5149/northcarolina/9781469630625.001.0001

Show Summary Details
Page of

PRINTED FROM UNIVERSITY OF NORTH CAROLINA PRESS SCHOLARSHIP ONLINE (www.northcarolina.universitypressscholarship.com). (c) Copyright University of North Carolina Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in NCSO for personal use.date: 27 October 2021

Triumph and Tragedy

Triumph and Tragedy

(p.76) Chapter Four Triumph and Tragedy
Prescription for Change

Michael Kinch

University of North Carolina Press

Industry growth mirrored innovation taking place in all aspects of understanding disease and ways to ameliorate it. All of this knowledge was needed to tackle the most deadly disease of modern times, HIV/AIDS. The surprisingly old history of a modern disease is related as well as the role that a key research organization, the National Institutes of Health (NIH), played in combatting the deadly virus. We also demonstrate how serendipity intervened in the form of a set of failed cancer medicines developed by a Detroit scientist years before AIDS was widely recognized. The discovery and advancement of pain-relieving medicines, from aspirin to Vioxx, is related. The triumphs and tragedies of these needed medicines fave rise to patient activism and critique of the FDA, some of which reflects an imbalance between resource availability and reactions to over- and under-regulation.

Keywords:   HIV/AIDS, Aspirin, Vioxx, FDA

North Carolina Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .